Please assess the completion status of the following clinical trial:

Trial Title: Carbon Ion Radiotherapy for the Treatment of Chinese Hepatocellular Carcinoma

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. histologically confirmed hepatocellular carcinoma (HCC) or clinical diagnosis of HCC according to American association for the study of liver diseases （AASLD）-guidelines or clinical diagnosis criteria based on Alpha Fetoprotein （AFP), and radiological images proposed by Liver Cancer Society, Chinese Anti-Cancer Association;~2. no clinically distant metastasis;~3. Child Push score A,technically unresectable, or medically inoperable; maximal tumor size is less than 12 cm;~4. age ≥ 18 and \<80 years of age;~5. Karnofsky Performance Score ≥ 70;~6. No previous invasive cancer (within 5 years before the HCC diagnosis)except for skin non-melanoma cancer or non muscle invasive bladder cancer; Ability to understand character and individual consequences of the clinical trial;~7. Willing to sign the written informed consent; Informed consent must be signed before the enrollment in the trial;~Exclusion Criteria:~1. Distant metastasis (M1);~2. maximal tumor size is more than 12 cm;~3. tumor invading adjacent gastrointestine (T4);~4. Child push score B or C;~5. Previous hepatic radiotherapy;~6. Severe systemic disorders;~7. Previous malignancy (within 5 years) except for skin non-melanoma cancer or 3-year disease free interval from previous malignancy like in situ cervix cancer or non muscle invasive bladder cancer;~8. Non conformity of the radiotherapy dose distribution when compared to the dose constraints;~9. Psychiatric disorders or any other condition that can make unreliable the informed consent;

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- carbon-ion radiotherapy for tumor away from GI (Type: EXPERIMENTAL): For tumor location which is away from gastrointestine (the distance is more than 1 cm). We use carbon-ion radiotherapy for the treatment of hepatocellular carcinoma. Four dose levels \[55 Gray equivalent (GyE)/10 fractions (Fx), 60GyE/10Fx, 65GyE/10Fx, 70GyE/10Fx\] are planned within the Phase I part.
- carbon-ion radiotherapy for tumor adjacent to GI (Type: EXPERIMENTAL): For tumor location which is adjacent to gastrointestine (less than 1 cm).We use carbon-ion radiotherapy for the treatment of hepatocellular carcinoma.~Three dose levels (carbon 60GyE/15Fx, carbon 67.5GyE/15Fx, carbon 75GyE/15Fx) are planned within the Phase I part.

Based on this trial design, predict the completion outcome and termination type (if applicable).